{"cluster": 62, "subcluster": 16, "abstract_summ": "Therefore, considering the exigency of the situation, we focused on identifying the available approved drugs as potential inhibitor against the promising Coronavirus drug target, the Main Protease, using computer-aided methods.Herein, we applied computational drug design methods to identify Chymotrypsin-like protease inhibitors from FDA approved antiviral drugs and our in-house database of natural and drug-like compounds of synthetic origin.It is noteworthy that Viomycin showed higher -CDocker energy as compared to the drugs currently under clinical trial for SARS-CoV-2 treatment viz.However, a combination of two HIV-1 protease inhibitors, lopinavir and ritonavir, has been found to be effective against SARS-CoV, and both drugs could bind well to the SARS-CoV 3C-like protease (SARS-CoV 3CL(pro)).In this work, molecular complexation between each inhibitor and SARS-CoV-2 3CL(pro) was studied using all-atom molecular dynamics simulations, free energy calculations, and pair interaction energy analyses based on MM/PB(GB)SA and FMO-MP2/PCM/6-31G* methods.", "title_summ": "Statins and the COVID-19 main protease: in silico evidence on direct interactionFDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replicationWhy Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019?Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico based approach.Identification of Chymotrypsin-like Protease Inhibitors of SARS-CoV-2 Via Integrated Computational Approach.Atomistic Insights into the Inhibitory Mechanisms", "title_abstract_phrases": "Therefore, considering the exigency of the situation, we focused on identifying the available approved drugs as potential inhibitor against the promising Coronavirus drug target, the Main Protease, using computer-aided methods.Herein, we applied computational drug design methods to identify Chymotrypsin-like protease inhibitors from FDA approved antiviral drugs and our in-house database of natural and drug-like compounds of synthetic origin.Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico based approach.However, a combination of two HIV-1 protease inhibitors, lopinavir and ritonavir, has been found to be effective against SARS-CoV, and both drugs could bind well to the SARS-CoV 3C-like protease (SARS-CoV 3CL(pro)).However, further research is necessary to investigate their potential use as drugs for COVID-19.FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replicationEmergent novel SARS-CoV-2 is responsible for the current pandemic outbreak of severe acute respiratory syndrome with high mortality among the symptomatic population worldwide."}